A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors

Clinical trial NCT02536183 · TERMINATED

Trial details

NCT number: NCT02536183
Sponsor: AeRang Kim
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Pediatric Cancer Solid Tumors Rhabdomyosarcoma Ewing Sarcoma Soft Tissue Sarcomas Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumors

Start date: 2016-10-01
Primary completion: 2022-10-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.